Focus on Alliance Management
Stefan Walke, Global Head of Alliance Management, dzieli się swoimi spostrzeżeniami dotyczącymi zarządzania aliansami i jego wkładem w rozwój udanych i długotrwałych partnerstw.
Szukaj
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come.
Być niezależnym
Kultura korporacyjna Boehringer Ingelheim opiera się na wartościach, które są stosowane od momentu założenia firmy w 1885 roku.
Equestrian sports technology
Learn about new trends in equine health and get insights into the human-horse relationship!
Trust Through Transparency
Trust Through Transparency
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
Stem cells a new frontier
Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Dane z rzeczywistej praktyki klinicznej potwierdzają wszechstronne korzyści terapii LAMA/LABA u pacjentów z POChP
Komunikaty prasowe
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages.
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Research Beyond Borders Partnering
Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
PREVEXXION®: szczepionki nowej generacji przeciwko chorobie Mareka są już dostępne w Unii Europejskiej
PREVEXXION®: szczepionki nowej generacji przeciwko chorobie Mareka są już dostępne w Unii Europejskiej
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE
Mutual benefit: Patient-centricity in clinical trials
Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.
Spesolimab - pozytywna opinia zalecająca zatwierdzenie nowych i rozszerzonych wskazań.
Spesolimab - pozytywna opinia zalecająca zatwierdzenie nowych i rozszerzonych wskazań.
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
Driving Innovation through Diversity & Inclusion
Driving innovation through diversity and inclusion. Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work.